A novel liver cancer therapy targeting tumour stroma [ 2016 - 2018 ]

Research Grant

Researchers: Prof Mark Gorrell (Principal investigator) ,  Prof Geoffrey Mccaughan

Brief description In Australia, there are 1,300 new cases of liver cancer each year with an average survival of 7 months. Liver cancer is now the most rapidly increasing cancer, probably caused by more hepatitis, obesity and diabetes. Our commercial partner has a novel innovative new antibody that shrinks other cancer types and we want to see how well it combats liver cancer in mice. This antibody has a raft of superior features and we have a clear plan towards making it available to patients.

Funding Amount $AUD 396,181.26

Funding Scheme Development Grants

Notes Development Grant